Could Thyroid-Stimulating Hormone Levels Predict Malignancy in Thyroid Nodules with Indeterminate Cytology? Relation between Thyroid-Stimulating Hormone Levels and Malignant Histology in Thyroid Nodules in the Indeterminate 2023 The Bethesda System for Reporting Thyroid Cytopathology Categories
Endocrinology Insights · 2025
DOI: 10.1159/000547118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology Insights, 2025. Verfasst von Mariana Mourão und 6 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The role of thyroid-stimulating hormone (TSH) level in predicting malignancy in thyroid nodules remains poorly understood, particularly in the clinical management of nodules with indeterminate cytology.
Methods
A retrospective review was performed on all adult patients with thyroid nodules cytologically classified as indeterminate (2023 The Bethesda System for Reporting Thyroid Cytopathology) who underwent surgery at a single tertiary care center over a 10-year period. Statistical analysis was performed to evaluate the association between preoperative TSH serum levels and histopathological results.
Results
A total of 252 patients were identified, of which 79 had nodules classified as atypia of undetermined significance and 173 as follicular neoplasms. In both groups, the mean TSH level in malignant nodules was lower than in benign nodules, although not significantly, with the former group having a mean TSH level of 1.46 mU/L versus 2.02 mU/L, p = 0.083, and the latter 1.54 mU/L versus 1.56 mU/L, p = 0.9.
Conclusion
The association between serum TSH levels and thyroid malignancy for the indeterminate Bethesda categories was not confirmed.
Zitieren
APA
Mourão, M., Guerreiro, S., Manso, N., Loureiro, I., Eusébio, R., Canberk, S., & Marques, H. P. (2025). Could Thyroid-Stimulating Hormone Levels Predict Malignancy in Thyroid Nodules with Indeterminate Cytology? Relation between Thyroid-Stimulating Hormone Levels and Malignant Histology in Thyroid Nodules in the Indeterminate 2023 The Bethesda System for Reporting Thyroid Cytopathology Categories. Endocrinology Insights. https://doi.org/10.1159/000547118
Vancouver
Mourão M, Guerreiro S, Manso N, Loureiro I, Eusébio R, Canberk S, et al. Could Thyroid-Stimulating Hormone Levels Predict Malignancy in Thyroid Nodules with Indeterminate Cytology? Relation between Thyroid-Stimulating Hormone Levels and Malignant Histology in Thyroid Nodules in the Indeterminate 2023 The Bethesda System for Reporting Thyroid Cytopathology Categories. Endocrinology Insights. 2025. doi:10.1159/000547118
BibTeX
@article{Mouro2025,
author = {Mourão, Mariana and Guerreiro, Sofia and Manso, Nuno and Loureiro, Isabel and Eusébio, Rosário and Canberk, Sule and Marques, Hugo Pinto},
title = {Could Thyroid-Stimulating Hormone Levels Predict Malignancy in Thyroid Nodules with Indeterminate Cytology? Relation between Thyroid-Stimulating Hormone Levels and Malignant Histology in Thyroid Nodules in the Indeterminate 2023 The Bethesda System for Reporting Thyroid Cytopathology Categories},
journal = {Endocrinology Insights},
year = {2025},
doi = {10.1159/000547118}
}
EUVIMED